Biotech · Private company
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Track this companyFree. Adds Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- EcallantidePhase 2 · Blood Loss, SurgicalClinicalTrials.gov · fetched Nov 12, 2026
- daptomycinPhase 1 · Gram-positive Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- daptomycinPhase 1 · Gram Positive InfectionClinicalTrials.gov · fetched Nov 12, 2026
- DaptomycinPhase 1 · Gram Positive Bacterial InfectionClinicalTrials.gov · fetched Nov 12, 2026
- daptomycinInfective EndocarditisClinicalTrials.gov · fetched Nov 12, 2026
- daptomycin and gentamicinInfective EndocarditisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Vancomycin-Associated NephrotoxicityCOMPLETED · started Nov 1, 2010ClinicalTrials.gov NCT01216540 · fetched Nov 12, 2026
- Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic AntibioticsPHASE1 · COMPLETED · started Jan 5, 2010ClinicalTrials.gov NCT01019395 · fetched Nov 12, 2026
- Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)PHASE4 · TERMINATED · started Feb 13, 2009ClinicalTrials.gov NCT00638157 · fetched Nov 12, 2026
- PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive InfectionsPHASE1 · COMPLETED · started Jun 3, 2008ClinicalTrials.gov NCT00679835 · fetched Nov 12, 2026
- Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/ReplacementPHASE2 · TERMINATED · started May 1, 2007ClinicalTrials.gov NCT00448864 · fetched Nov 12, 2026
- Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard AntibioticsPHASE1 · COMPLETED · started Aug 24, 2005ClinicalTrials.gov NCT00136292 · fetched Nov 12, 2026
- Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue InfectionsNA · COMPLETED · started Jun 1, 2005ClinicalTrials.gov NCT00261807 · fetched Nov 12, 2026